David Hering, Chief Executive Officer at Adagio Therapeutics, Inc. (ADGI), bought 8,000 shares at $4.52 ($36K) on 2022-09-01, disclosed to the SEC on 2022-09-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.